Abstract Research of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Fibromyalgia (FM), two acquired chronic illnesses affecting mainly females, has failed to ascertain their frequent ...
MIAMI - Pasithea Therapeutics Corp. (NASDAQ: KTTA), a micro-cap biotech firm with a market capitalization of $2.63 million focusing on developing treatments for central nervous system disorders and ...
Rapport Therapeutics (NASDAQ:RAPP – Get Free Report) will likely be posting its quarterly earnings results on Thursday, February 6th. Analysts expect Rapport Therapeutics to post earnings of ($0.62) ...
Researchers have conducted one of the largest eye studies in the world to reveal new insights into retinal thickness, highlighting its potential in the early detection of diseases like type 2 diabetes ...
A new drug-free, minimally invasive intervention targets the root cause of progressive loss of neural function in spinal ...
News Medical on MSN51m
New drug class may help alleviate IBS symptoms by targeting the central nervous systemIrritable bowel syndrome (IBS) is a common digestive disorder that affects the intestine, causing symptoms such as abdominal pain, bloating, gas, and changes in bowel habits, including diarrhea, ...
Compared with adults aged 65 and older, those aged 18 to 64 are more affected by long COVID neurologic symptoms.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback